Role of 5-HT1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 143-147

  Invernizzi, R ^a   Bramante, M ^a   Samanin, R ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

5 HT1A autoreceptors; Fluoxetine; Frontal cortex; Intracerebral microdialysis; Rat; Serotonin; WAY 100635

Indexed keywords

ANIMALIA;

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AUTORECEPTOR; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG POTENTIATION; FRONTAL CORTEX; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BODY WEIGHT; DRUG EFFECT; EXTRACELLULAR SPACE; FRONTAL LOBE; METABOLISM; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BODY WEIGHT; EXTRACELLULAR SPACE; FLUOXETINE; FRONTAL LOBE; MALE; MICRODIALYSIS; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029666427     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02159-0     Document Type: Article

References (27)

1. Artigas, F.; Perez, V.; Alvarez, E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychyatry 51:248-251; 1994.
2. Bel, N.; Artigas, F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study. Eur. J. Pharmacol. 229:101-103; 1992.
3. 1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology (Berlin) 117:358-363; 1995.
4. Caccia, S.; Bizzi, A.; Coltro, G.; Fracasso, C.; Frittoli, E.; Mennini, T.; Garattini, S. Anorectic activity of fluoxetine and norfluoxetine in rats: Relationship between brain concentrations and in vitro potencies on monoaminergic mechanisms. J. Pharm. Pharmacol. 44:250-254; 1992.
5. Chaput, Y.; deMontigny, C.; Blier, P. Effects of a selective 5-HT uptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 333:342-348; 1986.
6. 1A receptor antagonist. Br. J. Pharmacol. Suppl. 112:91P; 1994.
7. Fornal, C. A.; Meltzer, C. W.; Veasey, S. C.; McCreary, A. C.; Dourish, C. T.; Jacobs, B. L. Single-unit recording from freely moving animals provide evidence that WAY-100635, but not (S)-WAY-100135, blocks the action of endogenous serotonin at the 5-HT autoreceptor. Br. J. Pharmacol. Suppl. 112:92P; 1994.
8. Fuller, R. W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55:163-167; 1994.
9. Gardier, A. M.; Wurtman, R. J. Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration. Brain Res. 540:325-330; 1991.
10. 1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115:1064-1070; 1995.
11. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. Br. J. Pharmacol. 112:299P; 1994.
12. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study. J. Neurochem. 60:776-779; 1993.
13. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260:251-255; 1994.
14. 1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33:331-334; 1994.
15. 1 recognition sites. J. Rec. Res. 8:59-81; 1988.
16. Invernizzi, R.; Belli, S.; Samanin, R. An increase of extracellular serotonin in the dorsal raphe masks the effect of sertraline in the frontal cortex. In: Rollema, H.; Westerink, B. H. C.; Drijfhout, W. J., eds. Monitoring molecules in neuroscience - Proceedings of the 5th international conference on in vivo methods. Groningen: University Centre for Pharmacy; 1991:253-255.
17. Invernizzi, R.; Belli, S.; Samanin, R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584:322-324; 1992.
18. 1A receptors. Eur. J. Pharmacol. 260:243-246; 1994.
19. Invernizzi, R.; Bramante, M.; Samanin, R. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 696:62-66; 1995.
20. Kreiss, D. H.; Lucki, I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274:866-876; 1995.
21. McGuirk, J.; Muscat, R.; Willner, P. Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology (Berlin) 106:401-407; 1992.
22. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. Sydney: Academic Press; 1982.
23. Pazos, A.; Palacios, J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin, receptors. Brain Res. 346:205-230; 1985.
24. 2C receptors. Mol. Brain Res. 23:163-178; 1994.
25. Rutter, J. J.; Auerbach, S. B. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265:1319-1324; 1993.
26. Rutter, J. J.; Gundlah, C.; Auerbach, S. B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 171:183-186; 1994.
27. 1B receptor. EMBO J. 10:4017-4023; 1991.